You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EGFRt/19-28z/4-1BBL

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia (CLL), Relapsed, Refractory Trial in New York (EGFRt/19-28z/4-1BBL CAR T cells)

Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +2 more
  • EGFRt/19-28z/4-1BBL CAR T cells
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 1, 2022

CNS Lymphoma Trial in Duarte (procedure, biological, drug)

Recruiting
  • Central Nervous System Lymphoma
  • Aspiration
  • +10 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

B-Cell Lymphoma, Large B-cell Lymphoma, DLBCL, Nos Genetic Subtypes Trial in New York (19(T2)28z1xx TRAC T cell)

Recruiting
  • B-Cell Lymphoma
  • +4 more
  • 19(T2)28z1xx TRAC T cell
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Feb 24, 2023

Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

Recruiting
  • Pediatric Solid Tumor
  • +15 more
  • second generation 4-1BBζ EGFR806-EGFRt
  • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
  • Seattle, Washington
    Seattle Children's Hospital
May 2, 2022

Solid Tumors Trial in New York (procedure, drug, device, genetic)

Active, not recruiting
  • Solid Tumors
  • Production of Genetically-modified T cells
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 1, 2022

How do Perceptions of Coronavirus Disease Risk Influence Health

Recruiting
  • Pregnancy Related
    • Vancouver, British Columbia, Canada
    • +1 more
    Jan 9, 2023

    Glioblastoma Multiforme of Brain Trial in Duarte (CHM-1101 CAR-T cells)

    Not yet recruiting
    • Glioblastoma Multiforme of Brain
    • CHM-1101 CAR-T cells
    • Duarte, California
      City of Hope Medical Center
    Dec 19, 2022

    DLBCL, Not Otherwise Specified, Recurrent DLBCL, Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial in Seattle

    Terminated
    Has Results
    • Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
    • +5 more
    • Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ Central Memory T-lymphocytes JCAR014
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 1, 2022

    Recurrent Glioblastoma, Recurrent Malignant Glioma, Recurrent WHO Grade II Glioma Trial in Duarte (Chlorotoxin

    Recruiting
    • Recurrent Glioblastoma
    • +3 more
    • Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT delivery)
    • Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT/ICV dual delivery)
    • Duarte, California
      City of Hope Medical Center
    Feb 25, 2022

    Non-Hodgkin's Lymphoma, B-Cell ALL, B-Cell CLL Trial in Houston (CD19.CAR-CD28Z T Cells - dose escalation 2, CD19.CAR-CD28Z T

    Recruiting
    • Non-Hodgkin's Lymphoma
    • +2 more
    • CD19.CAR-CD28Z T Cells - dose escalation 2
    • CD19.CAR-CD28Z T Cells - dose escalation 1
    • Houston, Texas
    • +1 more
    Feb 10, 2022

    Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

    Active, not recruiting
    • Adult Grade III Lymphomatoid Granulomatosis
    • +23 more
    • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    COVID-19 Trial in Canada (mRNA-1273 SARS-CoV-2 vaccine, BNT162b2, ChAdOx1-S [recombinant])

    Recruiting
    • COVID-19
    • mRNA-1273 SARS-CoV-2 vaccine
    • +4 more
    • Edmonton, Alberta, Canada
    • +7 more
    Mar 7, 2022

    Depressive Symptoms, Physical Inactivity Trial in Vancouver (Exercise)

    Recruiting
    • Depressive Symptoms
    • Physical Inactivity
    • Exercise
    • Vancouver, British Columbia, Canada
      University of British Columbia
    May 16, 2022

    COVID-19 Trial in Canada, Poland, Romania (GS-5245, GS-5245 Placebo)

    Recruiting
    • COVID-19
    • Hamilton, Canada
    • +8 more
    Jan 24, 2023

    Head Neck Cancer Trial in London (Intra-tumoral T4 immunotherapy)

    Recruiting
    • Head and Neck Cancer
    • Intra-tumoral T4 immunotherapy
    • London, United Kingdom
      Clinical Research Facility, Guy's Hospital
    Mar 28, 2022

    COVID-19 Trial in Canada (Artesunate, Imatinib, Infliximab)

    Recruiting
    • COVID-19
    • Calgary, Alberta, Canada
    • +56 more
    Jan 12, 2023

    Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Transformed Chronic

    Not yet recruiting
    • Recurrent Transformed Chronic Lymphocytic Leukemia
    • +7 more
    • Biospecimen Collection
    • +9 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    May 15, 2023

    DLBCL, Grade 3b Follicular Lymphoma, Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial (biological, procedure, drug,

    Not yet recruiting
    • Diffuse Large B-Cell Lymphoma
    • +6 more
    • Axicabtagene Ciloleucel
    • +10 more
    • (no location specified)
    Jan 13, 2023

    Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma Trial in Seattle

    Recruiting
    • Recurrent Diffuse Large B-Cell Lymphoma
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Dec 30, 2022

    Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Richter Syndrome Trial

    Not yet recruiting
    • Recurrent Transformed Chronic Lymphocytic Leukemia
    • +2 more
    • Biopsy
    • +10 more
    • Duarte, California
      City of Hope Medical Center
    Jan 3, 2023

    Relapsed Non Hodgkin Lymphoma, Relapsed Adult ALL, Relapsed Pediatric ALL Trial in Calgary, Edmonton (autologous CD19-directed

    Recruiting
    • Relapsed Non Hodgkin Lymphoma
    • +2 more
    • autologous CD19-directed chimeric antigen receptor (CAR) T-cells
    • Calgary, Alberta, Canada
    • +5 more
    Jul 18, 2022

    Coronavirus Infections, Post-exposure Prophylaxis Trial in Vancouver, Toronto (Lopinavir/ritonavir)

    Active, not recruiting
    • Coronavirus Infections
    • Post-exposure Prophylaxis
    • Vancouver, British Columbia, Canada
    • +3 more
    Nov 29, 2021

    COVID-19 Trial in Brazil, Canada, United States (Convalescent plasma)

    Terminated
    Has Results
    • COVID-19
    • Convalescent plasma
    • Brooklyn, New York
    • +72 more
    Mar 1, 2022

    Brodalumab in Plaque Psoriasis to Understand Impact on Quality

    Recruiting
    • Psoriasis
    • Brodalumab
    • Matched cohort
    • Calgary, Alberta, Canada
    • +33 more
    Oct 8, 2022

    B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Chronic

    Terminated
    • B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged
    • +16 more
    • Autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T Cells
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    May 28, 2021